BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 27986364)

  • 1. The evolving clinical management of cerebral metastases.
    Sinha R; Sage W; Watts C
    Eur J Surg Oncol; 2017 Jul; 43(7):1173-1185. PubMed ID: 27986364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Melanoma brain metastases : Treatment options].
    Rauschenberg R; Tabatabai G; Troost EG; Garzarolli M; Beissert S; Meier F
    Hautarzt; 2016 Jul; 67(7):536-43. PubMed ID: 27206449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of brain metastases.
    Soffietti R; Rudā R; Mutani R
    J Neurol; 2002 Oct; 249(10):1357-69. PubMed ID: 12382150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [ANOCEF guidelines for the management of brain metastases].
    Le Rhun É; Dhermain F; Noël G; Reyns N; Carpentier A; Mandonnet E; Taillibert S; Metellus P;
    Cancer Radiother; 2015 Feb; 19(1):66-71. PubMed ID: 25666314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiotherapy and chemotherapy of brain metastases.
    Soffietti R; Costanza A; Laguzzi E; Nobile M; Rudà R
    J Neurooncol; 2005 Oct; 75(1):31-42. PubMed ID: 16215814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Chemotherapy and targeted therapies in the management of brain metastases].
    Carpentier AF
    Rev Prat; 2014 May; 64(5):679-81. PubMed ID: 24923060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metastases to the brain: current management perspectives.
    Nathoo N; Toms SA; Barnett GH
    Expert Rev Neurother; 2004 Jul; 4(4):633-40. PubMed ID: 15853582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiotherapy and immunotherapy: Can this combination change the prognosis of patients with melanoma brain metastases?
    Franceschini D; Franzese C; Navarria P; Ascolese AM; De Rose F; Del Vecchio M; Santoro A; Scorsetti M
    Cancer Treat Rev; 2016 Nov; 50():1-8. PubMed ID: 27566962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Front-line chemotherapy with cisplatin and etoposide for patients with brain metastases from breast carcinoma, nonsmall cell lung carcinoma, or malignant melanoma: a prospective study.
    Franciosi V; Cocconi G; Michiara M; Di Costanzo F; Fosser V; Tonato M; Carlini P; Boni C; Di Sarra S
    Cancer; 1999 Apr; 85(7):1599-605. PubMed ID: 10193952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new grading system focusing on neurological outcomes for brain metastases treated with stereotactic radiosurgery: the modified Basic Score for Brain Metastases.
    Serizawa T; Higuchi Y; Nagano O; Matsuda S; Ono J; Saeki N; Hirai T; Miyakawa A; Shibamoto Y
    J Neurosurg; 2014 Dec; 121 Suppl():35-43. PubMed ID: 25434935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multimodality treatment of melanoma brain metastases incorporating stereotactic radiosurgery (SRS).
    Samlowski WE; Watson GA; Wang M; Rao G; Klimo P; Boucher K; Shrieve DC; Jensen RL
    Cancer; 2007 May; 109(9):1855-62. PubMed ID: 17351953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of brain metastases: past, present, and future.
    Routh A; Khansur T; Hickman BT; Bass D
    South Med J; 1994 Dec; 87(12):1218-26. PubMed ID: 7973921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological implications of whole-brain radiotherapy versus stereotactic radiosurgery of multiple brain metastases.
    Xue J; Kubicek GJ; Grimm J; LaCouture T; Chen Y; Goldman HW; Yorke E
    J Neurosurg; 2014 Dec; 121 Suppl():60-8. PubMed ID: 25434938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of stereotactic radiosurgery with and without whole-brain radiotherapy for the treatment of newly diagnosed brain metastases.
    Hall MD; McGee JL; McGee MC; Hall KA; Neils DM; Klopfenstein JD; Elwood PW
    J Neurosurg; 2014 Dec; 121 Suppl():84-90. PubMed ID: 25434941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of melanoma brain metastases: a new paradigm.
    Carlino MS; Fogarty GB; Long GV
    Cancer J; 2012; 18(2):208-12. PubMed ID: 22453023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multidisciplinary management of brain metastases.
    Eichler AF; Loeffler JS
    Oncologist; 2007 Jul; 12(7):884-98. PubMed ID: 17673619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of brain metastases.
    Matzenauer M; Vrana D; Melichar B
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2016 Dec; 160(4):484-490. PubMed ID: 27876898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors for survival in patients treated with stereotactic radiosurgery for recurrent brain metastases after prior whole brain radiotherapy.
    Caballero JA; Sneed PK; Lamborn KR; Ma L; Denduluri S; Nakamura JL; Barani IJ; McDermott MW
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):303-9. PubMed ID: 22079723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain metastases: treatment options to improve outcomes.
    Davey P
    CNS Drugs; 2002; 16(5):325-38. PubMed ID: 11994022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival and prognostic factors in patients with brain metastases from malignant melanoma.
    Meier S; Baumert BG; Maier T; Wellis G; Burg G; Seifert B; Dummer R
    Onkologie; 2004 Apr; 27(2):145-9. PubMed ID: 15138346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.